NewcelX Ltd.

Market Cap

$19M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.49+$1.40 (+66.99%)

Jun 22, 2026

52W High $29.0052W Low $1.88

Company Details

NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the tre...

Leadership

Ronen Twito CPA

CEO & Executive Chairman

Michel Revel M.D., Ph.D.Founder

Co-Founder, Chief Scientist, Head of the Scientific Advisory Board & Director

Omri Hagai

Chief Financial Officer

Alexander C. Zwyer M.B.A.

Chief Business Officer & Executive Director

Eric Konofal M.D., Ph.D.

Head of Doxa Program

Yossi Ben-Yossef

Honorary President & Strategic Consultant

Ariel Revel M.D.

Director of Medical Affairs

IPO Date

Jan 29, 2021

Website

newcelx.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$4M

EPS (Diluted)

Free Cash Flow

-$6M

Revenue / Share

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Operating Cash Flow

CapEx Spend

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding